Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies.

Selvan SR, Dowling JP, Kelly WK, Lin J. Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies. Curr Cancer Drug Targets. 2016; 16(9):755-764.

View in: PubMed